New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
12:13 EDTGALT, UPS, FTR, PGTI, PFE, CTL, MW, MRK, WINOn The Fly: Midday Wrap
Stocks on Wall Street were mixed at midday despite a much better than expected consumer confidence reading and better than expected earnings from two pharmaceutical giants. With the Fed currently conducting its two-day FOMC meeting, investors may be choosing to remain cautious ahead of tomorrow’s conclusion. The averages have weakened in the last hour and are now mixed, with the Nasdaq leading and the S&P 500 lagging, but all of the major averages are not far from their starting points. ECONOMIC EVENTS: In the U.S., the S&P Case Shiller home price index rose 9.34% from the prior year in May to 170.64, which was a bit below the expectation for a 9.9% year-over-year increase. The Conference Board's consumer confidence reading climbed to 90.9 in July from an upwardly revised 86.4 June figure, beating expectations for a 85.4 reading and reaching its highest level since October 2007. COMPANY NEWS: Windstream (WIN) jumped 12% and sent ripples throughout the telecom sector after announcing plans to spin off certain telecommunications network assets into an independent, publicly traded Real Estate Investment Trust, or REIT. Windstream confirmed it has received a private letter ruling from the Internal Revenue Service relating to certain tax matters regarding the tax-free nature of the spinoff and the qualification of the spunoff entity's assets as real property for REIT purposes. In addition to Windstream, shares of other companies that provide communications services gained as they were viewed as potentially being positioned to pursue similar plans, with Frontier Communications (FTR) advancing 11% and CenturyLink (CTL) rising 4%. However, Morgan Stanley cautioned that this ruling could reopen the political debate on REIT exemptions, especially if bigger companies begin to explore them, while UBS said large Telcos such as AT&T (T) and Verizon (VZ) are unlikely to consider a similar structural separation... UPS (UPS) fell 3.5% after reporting Q2 adjusted earnings per share that missed expectations and lowering its fiscal year earnings outlook, citing its plans to increase operating expenses for capacity and peak related projects to a total of $175M. “These initiatives will increase operating expense this year, but will provide financial benefits for years to come,” said UPS CFO Kurt Kuehn... Two Dow members and pharma giants, Pfizer (PFE) and Merck (MRK), both reported sales and profits that beat expectations for their second quarters. Pfizer, which backed its fiscal year adjusted EPS view but lowered its adjusted revenue view for the year, fell 0.4%, while Merck gained 1.6% near noon after its own report. MAJOR MOVERS: Among the notable gainers was windows and door supplier PGT Inc. (PGTI), which gained 28% after reporting better than expected quarterly results and agreeing to buy CGI Windows & Doors for about $111M. Among the noteworthy losers was Men's Wearhouse (MW), which fell 7% after the company gave long-term guidance during its analyst day meeting. Also lower was Galectin Therapeutics (GALT), which plunged 55% after the company posted a presentation on its website that contains a summary of the results of the second cohort of patients in the Phase 1 clinical trial for GT-020. Galectin's GR-MD-02 showed no difference from placebo across most efficacy biomarkers in the phase I study of nonalcoholic steatohepatitis, according to The Street's Adam Feuerstein. INDEXES: Near midday, the Dow was down 1.79, or 0.01%, to 16,980.80, the Nasdaq was up 8.00, or 0.18%, to 4,452.91, and the S&P 500 was down 1.91, or 0.1%, to 1,977.00.
News For WIN;CTL;FTR;MRK;PFE;UPS;MW;PGTI;GALT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 20, 2015
13:41 EDTFTREarnings Watch: Verizon shares up marginally since Q4 results
Verizon Communications (VZ) is expected to report first quarter earnings before the market open on Tuesday, April 21, with a conference call scheduled for 8:30 am ET. Verizon is a holding company providing communications, information and entertainment. EXPECTATIONS: Analysts are looking for earnings per share of 95c on revenue of $32.27B, according to First Call. The consensus range for EPS is 89c-$1.00 on revenue of $31.74B-$32.97B. LAST QUARTER: Verizon reported fourth quarter adjusted EPS of 71c against estimates for 72c on revenue of $33.19B against estimates for $32.69B. For Q4 in Wireless, the company reported 2.1M net retail connections; 2.0M net retail postpaid connections, including net additions of 672,000 postpaid phones; retail postpaid churn of 1.14%; 108.2M total retail connections and 102.1M total retail postpaid connections. In Wireline, it reported 4.1% year-over-year quarterly increase in consumer revenues. Verizon reported Q4 retail postpaid ARPA, or average revenue per account, increased 1.0% over Q4 of 2013 to $158.82 per month, and 3.9% over the full year. Verizon reported Q4 FiOS consumer revenue growth of 11.1%; 6.6M FiOS Internet subscribers, with 145K net additions; 5.6M FiOS Video subscribers, with 116K net additions. For 2015, Verizon expects consolidated revenue growth of at least 4%. It sees sustained profitability with a consolidated adjusted EBITDA margin at a level consistent with full-year 2014 performance. It also expects strong free cash flow generation with consolidated capital spending of $17.5B-$18.0B. On February 5, Frontier Communications (FTR) announced a definitive agreement with Verizon under which Frontier will acquire Verizon’s wireline operations that provide services to residential, commercial and wholesale customers in California, Florida and Texas, for $10.54B in cash. On the same day, Verizon announced a $5B accelerated share-repurchase program and agreed to lease the rights to over 11,300 of its company-owned wireless towers to American Tower (AMT), which will also purchase approximately 165 Verizon towers, for a total upfront payment of approximately $5B. American Tower will have exclusive rights to lease and operate over 11,300 Verizon cell towers, a significant majority of the towers the company currently owns. In addition, Verizon will sell approximately 165 towers outright. On March 10 at the Deutsche Bank Media, Internet & Telecom Conference, CFO Fran Shammo said there was “not much change” in the competitive environment since Q4-end, Q1 volume should return to "more normal levels," and Q1 churn is likely to be elevated from year ago, but not "something that is going to be concerning." PRICE ACTION: Verizon’s shares are up marginally since the company's Q4 report. Over the past twelve months, they are up about 3.3%. In afternoon trading ahead of Tuesday's Q1 report, Verizon’s shares are up 0.5%.
08:37 EDTWINBofA/Merrill U.S. telecom analysts hold an analyst/industry conference call
Subscribe for More Information
08:05 EDTMRKTetraLogic, Merck enter into oncology clinical study collaboration
Subscribe for More Information
08:02 EDTPFEMerck KGaA, Pfizer initiate Phase III study with Avelumab
Subscribe for More Information
07:20 EDTMRKAmerican Association for Cancer Research to hold annual meeting
Subscribe for More Information
06:05 EDTPFEProvectus receives notice of allowance for PV-10 combined with other drugs
Subscribe for More Information
April 19, 2015
19:35 EDTMRKMerck to swiftly repay $5B loan, explore acquisitions by late 2017, Reuters says
Subscribe for More Information
15:21 EDTMRKMerck announces new data from Keytruda study
Subscribe for More Information
14:59 EDTMRKMerck's Keytruda 'superior' to ipilimumab for PFS in patients with melanoma
Subscribe for More Information
14:47 EDTMRKMerck submits supplemental biologics license for Keytruda in lung cancer
Subscribe for More Information
14:31 EDTMRKMerck reports 28% Keytruda response rate in 25 pleural mesothelioma patients
Subscribe for More Information
April 17, 2015
08:08 EDTMWMen's Wearhouse recommended at Goldman
Subscribe for More Information
April 16, 2015
13:01 EDTMWJos. A. Bank to scale back on suit discounts, Business Insider reports
Men's Wearhouse is scaling back on the discounts for Jos. A. Bank, reports Business Insider. CEO Doug Ewert said the "buy-one, get-several free" deals are no longer sustainable, adding that the company "sees an opportunity to expand on other reasons to shop at Jos. A. Bank, beyond just deep discounts. Reference Link
April 15, 2015
08:33 EDTMRKFDA panel results positive for Merck, says SunTrust
Subscribe for More Information
08:04 EDTPFEPfizer: PALOMA-3 trial for IBRANCE met primary endpoint, trial stopped early
Subscribe for More Information
April 14, 2015
13:32 EDTMRKMerck, NewLink Genetics confirm initiation of Phase 3 trial of Ebola vaccine
Subscribe for More Information
07:10 EDTUPSAviation Week to hold a conference
MRO Americas 2015 is being held in Miami Beach on April 14-16.
April 13, 2015
20:16 EDTWIN, FTR, CTLUSTelecom files net neutrality lawsuit against FCC
Subscribe for More Information
15:12 EDTPFEMylan enters settlement, license agreement with Pfizer regarding Viagra
Mylan (MYL) announced that its subsidiaries Mylan Inc. and Mylan Pharmaceuticals have entered into a settlement and license agreement with Pfizer (PFE), Pfizer Limited and Pfizer Ireland Pharmaceuticals to settle patent litigation relating to Mylan's Abbreviated New Drug Application filed with the U.S. FDA for Sildenafil Citrate Tablets 25 mg, 50 mg, and 100 mg. This product is the generic version of Viagra, which is indicated to treat erectile dysfunction. Under the terms of the agreement, Mylan will be able to launch its ANDA products pursuant to a royalty-bearing license as early as December 11, 2017, or sooner under certain conditions, subject to FDA approval. All other terms and conditions of the settlement and license agreement are confidential, and the agreement itself is subject to review by the U.S. Department of Justice and the Federal Trade Commission. For the 12 months ending Dec. 31, 2014, Viagra had U.S. sales of approximately $1.3B, according to IMS Health.
08:58 EDTMRKMerck may have positive read through from briefing docs, says SunTrust
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use